- Business
- Dai Nippon Printing Co., Ltd. (DNPCF) is a leading Japanese printing and information technology company that manufactures and supplies a diverse range of products across electronics, lifestyle and industrial supplies, and information communication segments; core offerings include display components such as shadow masks, color filters, optical films, and OLED evaporation masks; precision devices like photomasks, nanoimprinted products, and microfabricated components for semiconductors, vehicles, energy, and life sciences; functional films for light, heat, and water control in packaging, electronics, and automobiles; industrial materials for manufacturing efficiency and environmental reduction; packaging solutions encompassing eco-friendly, aseptic filling, and pharmaceutical barrier films; decorative printed materials using electron beam technology for interiors; mobility solutions for digitalization and eco-friendly transport; healthcare products including regenerative medicine scaffolds and biotech packaging; printing and processing services for publications and commercial needs; photo imaging with dye-sublimation printers, media, and secure systems; and business solutions featuring holograms, card printers, smart cards, and VR/AR technologies. Founded in 1876 and headquartered in Tokyo, the company operates globally with bases in North America, Europe, Asia, and Indonesia, serving consumer, industrial, pharmaceutical, and electronics markets through subsidiaries like DNP Imagingcomm America Corporation and recent integrations. In recent developments, DNP acquired a controlling 75% stake in Laxton's holding company Rubicon SEZC in July 2025 to expand identity and biometrics solutions, completed the acquisition of all shares in HK Holding operating Hikari on January 31, 2025, established its first overseas R&D hub in the Netherlands in July 2025 for co-packaged optics and photonics, launched a 2,500 mm-width coating line in 2025 boosting production capacity by 15%, developed new high-barrier PP films and PTP lids for pharmaceuticals in July 2025, partnered with SCIVAX in 2023 for nanoimprint foundry services via Nanosol aiming for 10 billion yen sales by 2026, invested in xID in July 2024 and monoAI technology in May 2024, and announced multiple share buybacks in 2025 to enhance shareholder value.